{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:50:04Z","timestamp":1792684204897,"version":"4.5.0"},"reference-count":72,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamapsychiatry.2018.0768","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T16:35:35Z","timestamp":1525883735000},"page":"713","source":"Crossref","is-referenced-by-count":141,"title":["Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy\/Psychotherapy for Treatment-Resistant Depression in the United States"],"prefix":"10.1001","volume":"75","author":[{"given":"Eric L.","family":"Ross","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Zivin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"},{"name":"Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor"},{"name":"Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Maixner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"yoi180026r1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamapsychiatry.2017.1670","article-title":"Modern electroconvulsive therapy: vastly improved yet greatly underused.","volume":"74","author":"Sackeim","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi180026r2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bdi.2012.14.issue-2","article-title":"Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis.","volume":"14","author":"Dierckx","year":"2012","journal-title":"Bipolar Disord"},{"issue":"4","key":"yoi180026r3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.","volume":"65","author":"Husain","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"yoi180026r4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"8","key":"yoi180026r5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamapsychiatry.2017.1378","article-title":"Association of electroconvulsive therapy with psychiatric readmissions in US hospitals.","volume":"74","author":"Slade","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi180026r6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1176\/ajp.155.1.22","article-title":"Use of ECT for the inpatient treatment of recurrent major depression.","volume":"155","author":"Olfson","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi180026r7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/YCT.0b013e3182a6ad0d","article-title":"The role of ECT in suicide prevention.","volume":"30","author":"Fink","year":"2014","journal-title":"J ECT"},{"issue":"5","key":"yoi180026r8","first-page":"370","article-title":"Cost burden of treatment resistance in patients with depression.","volume":"16","author":"Gibson","year":"2010","journal-title":"Am J Manag Care"},{"issue":"12","key":"yoi180026r9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1176\/appi.ajp.2012.12050648","article-title":"ECT in treatment-resistant depression.","volume":"169","author":"Kellner","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi180026r10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis.","volume":"30","author":"Heijnen","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"yoi180026r11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/brb3.37","article-title":"Contemporary use and practice of electroconvulsive therapy worldwide.","volume":"2","author":"Leiknes","year":"2012","journal-title":"Brain Behav"},{"issue":"9","key":"yoi180026r13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0706743716660033","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder, section 4: neurostimulation treatments.","volume":"61","author":"Milev","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"7","key":"yoi180026r15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archgenpsychiatry.2009.75","article-title":"Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.","volume":"66","author":"Sackeim","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi180026r17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/YCT.0b013e3181da84c6","article-title":"Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression.","volume":"27","author":"Rasmussen","year":"2011","journal-title":"J ECT"},{"issue":"2","key":"yoi180026r18","first-page":"123","article-title":"Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.","volume":"17","author":"Vlahiotis","year":"2011","journal-title":"J Manag Care Pharm"},{"issue":"9","key":"yoi180026r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9090","article-title":"Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.","volume":"9","author":"Greenhalgh","year":"2005","journal-title":"Health Technol Assess"},{"issue":"7","key":"yoi180026r20","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291714002554","article-title":"Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.","volume":"45","author":"Vallejo-Torres","year":"2015","journal-title":"Psychol Med"},{"issue":"1","key":"yoi180026r21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough.","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"yoi180026r22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","article-title":"A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study.","volume":"173","author":"Kellner","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi180026r23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/acp.2010.121.issue-6","article-title":"Electroconvulsive therapy is equally effective in unipolar and bipolar depression.","volume":"121","author":"Bailine","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"yoi180026r24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1034\/j.1399-5618.2001.030208.x","article-title":"ECT in bipolar and unipolar depression: differences in speed of response.","volume":"3","author":"Daly","year":"2001","journal-title":"Bipolar Disord"},{"issue":"1","key":"yoi180026r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7547-10-1","article-title":"Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.","volume":"10","author":"Zimovetz","year":"2012","journal-title":"Cost Eff Resour Alloc"},{"key":"yoi180026r26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jad.2015.02.011","article-title":"Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders.","volume":"178","author":"Forte","year":"2015","journal-title":"J Affect Disord"},{"issue":"10","key":"yoi180026r28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine.","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"yoi180026r29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness: the curious resilience of the $50,000-per-QALY threshold.","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"yoi180026r30","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"yoi180026r31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS): explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Good Reporting Practices Task Force.","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"issue":"3","key":"yoi180026r32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1017\/S0033291716002737","article-title":"Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials.","volume":"47","author":"Kolshus","year":"2017","journal-title":"Psychol Med"},{"issue":"3","key":"yoi180026r33","first-page":"1","article-title":"United States life tables, 2013.","volume":"66","author":"Arias","year":"2017","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"yoi180026r34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","article-title":"Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses.","volume":"171","author":"Cuijpers","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"4","key":"yoi180026r35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00213-007-0975-9","article-title":"Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.","volume":"196","author":"Weinmann","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"yoi180026r36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bdi.2009.11.issue-4","article-title":"Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.","volume":"11","author":"Sienaert","year":"2009","journal-title":"Bipolar Disord"},{"issue":"1-3","key":"yoi180026r37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2009.01.014","article-title":"Response to ECT in bipolar I, bipolar II and unipolar depression.","volume":"118","author":"Medda","year":"2009","journal-title":"J Affect Disord"},{"key":"yoi180026r38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1034\/j.1399-5618.4.s1.40.x","article-title":"Response to ECT in major depression: are there differences between unipolar and bipolar depression?","volume":"4","author":"Grunhaus","year":"2002","journal-title":"Bipolar Disord"},{"issue":"6","key":"yoi180026r39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/JGP.0b013e318170a6fa","article-title":"Continuation\/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.","volume":"16","author":"Navarro","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"yoi180026r40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/YCT.0b013e318276591f","article-title":"Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.","volume":"29","author":"Nordenskj\u00f6ld","year":"2013","journal-title":"J ECT"},{"issue":"10","key":"yoi180026r41","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1038\/npp.2009.50","article-title":"When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study.","volume":"34","author":"Perlis","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"yoi180026r42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-2-20","article-title":"Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.","volume":"2","author":"Sapin","year":"2004","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"yoi180026r43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs.","volume":"63","author":"Crown","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi180026r44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4088\/JCP.v65n0309","article-title":"The cost consequences of treatment-resistant depression.","volume":"65","author":"Russell","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"yoi180026r45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00124509-199812000-00007","article-title":"Reimbursement and documentation issues in an ambulatory ECT program.","volume":"14","author":"Bailine","year":"1998","journal-title":"J ECT"},{"issue":"9","key":"yoi180026r46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder, section 3: pharmacological treatments.","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"3","key":"yoi180026r47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000442293","article-title":"Suicides and suicide attempts during long-term treatment with antidepressants: a meta-analysis of 29 placebo-controlled studies including 6,934 patients with major depressive disorder.","volume":"85","author":"Braun","year":"2016","journal-title":"Psychother Psychosom"},{"issue":"8","key":"yoi180026r48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/0269881107083808","article-title":"A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.","volume":"22","author":"Papakostas","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"8","key":"yoi180026r49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1176\/appi.ps.201300059","article-title":"A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.","volume":"65","author":"Mrazek","year":"2014","journal-title":"Psychiatr Serv"},{"key":"yoi180026r51","article-title":"Adjusting health expenditures for inflation: a review of measures for health services research in the United States [published online November 21, 2016].","author":"Dunn","journal-title":"Health Serv Res"},{"issue":"1-3","key":"yoi180026r52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jad.2009.04.017","article-title":"Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.","volume":"120","author":"Benedict","year":"2010","journal-title":"J Affect Disord"},{"key":"yoi180026r53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pnpbp.2014.02.004","article-title":"Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.","volume":"51","author":"Ren","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"yoi180026r54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/01.yct.0000176972.72777.c4","article-title":"Length of the ECT course in bipolar and unipolar depression.","volume":"21","author":"Sackeim","year":"2005","journal-title":"J ECT"},{"issue":"12","key":"yoi180026r55","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archpsyc.63.12.1337","article-title":"Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).","volume":"63","author":"Kellner","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"yoi180026r56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","article-title":"Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis.","volume":"68","author":"Semkovska","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"1-3","key":"yoi180026r57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jad.2012.10.018","article-title":"Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.","volume":"147","author":"McCall","year":"2013","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi180026r58","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"issue":"4","key":"yoi180026r60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000226611","article-title":"Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.","volume":"59","author":"Amsterdam","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"6","key":"yoi180026r61","first-page":"e357","article-title":"Cost-effectiveness of combinatorial pharmacogenomic testing for treatment-resistant major depressive disorder patients.","volume":"21","author":"Hornberger","year":"2015","journal-title":"Am J Manag Care"},{"issue":"12","key":"yoi180026r62","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/npp.2013.149","article-title":"Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.","volume":"38","author":"Jelovac","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi180026r63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12888-017-1385-0","article-title":"Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.","volume":"17","author":"Gauthier","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"2","key":"yoi180026r65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/YCT.0b013e318205c7d7","article-title":"Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.","volume":"27","author":"McCall","year":"2011","journal-title":"J ECT"},{"issue":"7","key":"yoi180026r66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","article-title":"Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).","volume":"11","author":"Ara","year":"2008","journal-title":"Value Health"},{"issue":"8","key":"yoi180026r67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archgenpsychiatry.2010.82","article-title":"Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.","volume":"67","author":"Pyne","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"yoi180026r68","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4088\/JCP.16cs10885","article-title":"Florida best practice psychotherapeutic medication guidelines for adults with major depressive disorder.","volume":"78","author":"McIntyre","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi180026r69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/YCT.0b013e3181f9789c","article-title":"Factors that influence electroconvulsive therapy referrals: a statewide survey of psychiatrists.","volume":"27","author":"Dauenhauer","year":"2011","journal-title":"J ECT"},{"issue":"5","key":"yoi180026r70","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.","volume":"67","author":"Dunner","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"yoi180026r71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archpsyc.57.5.425","article-title":"A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.","volume":"57","author":"Sackeim","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"23","key":"yoi180026r72","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1001\/jama.289.23.3135","article-title":"Cost of lost productive work time among US workers with depression.","volume":"289","author":"Stewart","year":"2003","journal-title":"JAMA"},{"key":"yoi180026r12","volume-title":"The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging","author":"American Psychiatric Association Committe on Electroconvulsive Therapy","year":"2001","edition":"2nd ed"},{"key":"yoi180026r27","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"yoi180026r59","author":"Taylor","year":"2016"},{"key":"yoi180026r64","author":"Olfson","year":"2017"},{"key":"yoi180026r14","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. http:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf. Accessed August 27, 2017."},{"key":"yoi180026r16","unstructured":"Centers for Medicare and Medicaid Services. Inpatient psychiatric facility prospective payment system. https:\/\/www.cms.gov\/Outreach-and-Education\/Medicare-Learning-Network-MLN\/MLNProducts\/Downloads\/Inpatient-Psychiatric-Facility-Prospective-Payment-System-Text-Only.pdf. Accessed August 11, 2017."},{"key":"yoi180026r50","unstructured":"Bureau of Economic Analysis. Medical care expenditure indices from MEPS. https:\/\/www.bea.gov\/national\/health_care_satellite_account.htm. Accessed August 11, 2017."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2680312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:02:48Z","timestamp":1720285368000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.0768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.0768","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}